Germany And Netherlands Medical Marijuana Market Size, Share & Trends Analysis Report By Product (Flower, Oil), By Application (Chronic Pain, Mental Disorder, Cancer), By Country, And Segment Forecasts, 2020 - 2027
Germany And Netherlands Medical Marijuana Market Growth & Trends
The Germany and Netherlands medical marijuana market size is expected to reach USD 2.9 billion by 2027., expanding at a CAGR of 13.0% over the forecast period. The growing adoption of marijuana for the treatment of chronic diseases is positively impacting the growth. Furthermore, increasing its legalization and use for therapeutic purposes is further bolstering revenue growth over the forecast period.
Based on the product, the flower segment dominated the market in 2019.Flowers are generally utilized for smoking purposes and have applications in a variety of health-related conditions such as in the treatment of glaucoma and nausea.
Such factors are contributing to the increase in demand for the flower. In addition, rapid onset of action with respect to the smoking of flowers and its applications in alleviating chronic pain, reducing cancer, stopping the progression of Alzheimer’s disease is further propelling the market growth.
In 2019, the chronic pain segment accounted for the highest revenue share.This growth is attributed to the presence of legal programs in both the countries and its increasing acceptance for various chronic conditions.
In addition, scientific literature supporting its benefits in the treatment of various diseases, including chronic pain is further fueling the growth.
Germany dominated the market with a revenue share of 98.0% in 2019 owing to the increasing population and high demand for medical use. Furthermore, liberal government regulations, sanctioning of cultivation licenses in the country, and its legalization for health-related or therapeutic purposes are boosting the growth of the market in the country.
Germany And Netherlands Medical Marijuana Market Report Highlights • Increasing adoption of marijuana for the treatment of chronic diseases and its legalization to be used for therapeutic purposes is driving the market
• The flower segment dominated the market in 2019, owing to the rising number of applications in a variety of health-related conditions such as treatment of glaucoma and nausea.
• The chronic pain segment dominated the market in 2019, owing to the presence of legal programs in both the countries and increasing acceptance of medical marijuana to treat various chronic conditions.
• Germany dominated the market with a revenue share of 98.0% in 2019, owing to the increasing population of the country and high demand for medical use.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
KEY FINDINGS The Europe biosurgery market is predicted to record a CAGR of 6.16% during the forecasted years of 2021 to 2028. Factors such as the growing burden of chronic conditions likely to cause physical disability, the increasing adoption of new and advanced surgical products, as well as the rising number of surgeries...
KEY FINDINGS The global cartilage repair market is projected to record a CAGR of 15.42% during the forecast period, 2021-2028. The factors fueling the market growth are the rising geriatric population, the increasing sports injuries, and the growing prevalence of obesity. MARKET INSIGHTS Cartilage...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate (CAGR) of -6.27%. The decline...
KEY FINDINGS The Germany fish oil market is expected to register a CAGR of 8.14% in terms of volume, and 9.92% in terms of revenue, during the forecast years. The increased demand for tailor-made omega-3 products and the rising health awareness concerning chronic diseases, predominantly drive the country’s fish oil market....
The Europe electronic skin patches market is registered to project a CAGR of 16.41%, during the forecast years of 2021 to 2028. The region’s key market growth drivers are, the surging number of research and development activities, the rising healthcare expenditure, and the increasing geriatric population.
The Europe 3D Ultrasound Market would witness market growth of 8% CAGR during the forecast period (2020-2026). The driving elements for the development of the ultrasound devices market incorporate the government and private subsidizing for R&D in ultrasound imaging, an expanding number of medical care suppliers, development in technology,...
17 pages •
By Euromonitor International
• Nov 2020
After peaking in 2024, depopulation will occur in Germany up to 2040 as falling net migration rates are no longer able to mitigate increasingly negative natural change. As birth rates drop and longevity climbs, ageing will accelerate transforming consumer trends and putting additional pressure on state resources. Urbanisation will continue...
The Europe Urinary Drainage Bags Market would witness market growth of 5.4% CAGR during the forecast period (2020-2026). The swift increase in the geriatric population is the main factor that is responsible for the growing demand for urinary drainage bags. Numerous changes occur in the urinary system of an old person such as weakening...
Genitourinary System Disease
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.